We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Touchstone | IVO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 315.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 315.00 |
| Top Posts |
|---|
Posted at 24/8/2017 12:10 by luafc If IPO continues to fall, it seems IVO and its management are totally powerless in turn to stop the IVO share price falling away in sympathy - with the same big investors in both companies continuing to support the "merger" at roughly 2.21 IPO for 1 IVO.Interestingly, the deal puts a cap on the upside with terms adjusted should 330p on IVO be hit, but AFAIK, there's no downside protection on IVO. One of those City skews... The IVO NAV is currently rendered redundant and irrelevant in buttressing the share price Unsatisfactory and (surely) unfair to IVO holders. |
Posted at 04/7/2017 12:29 by luafc AB:SP movement is currently more outside IVO's control than ever. The same big investors in both IP Group and IVO seem largely supportive of a takeover by IP Group of IVO at 2.1575 shares in IPO for each IVO - which pretty well sets today's price (IPO currently at about 128.) Management of IVO are not supportive advising shareholders to take no action at this time citing undervaluation as one reason of concern - but their power/sway seems limited by the big investors. The way (perhaps) to protect yourself from this arguably low ball offer is to consider buying IP shares. Personally, I think IVO shareholders without compensating holdings in IPO are being taken for a journey. |
Posted at 12/4/2014 16:36 by visio I noticed that too. The only thing I have found is this;'I must confess I have always had a soft spot for Imperial Innovations, the company that invests in technologies developed at some of the UK's top universities. Its origins lie just around the corner from the Evening Standard's Kensington office, in Exhibition Road where Imperial College resides. Imperial Innovations was set up as the technology transfer office for the college in 1986. It floated 20 years later, raising £25 million through a share offer at 365p that valued it at £180 million. There have been a couple more fund-raisers totalling just over £180 million since then. The market cap has inched its way up to just over £410 million. The shares have gone from 365p to 412p in eight years. That's hardly shooting the lights out - but look at the price over just the last seven months, and it has come up an impressive 58%. What's going on? Two things: in 2011, Imperial extended its technological tie-ups to take in research at University College London, Oxford and Cambridge. Talk to chief executive Russell Cummings, and you find the technology being done by investee companies more often comes from at least two of these centres of learning rather than just one. Second, as recent half-year results showed, Innovations is a maturing company. From a handful of investments when it floated, it now has holdings in well over 30 companies. These generally take between eight and 12 years to come to fruition, normally through a flotation. The recent big one was cat-allergy treatment developer Circassia, which floated last month with a value of £581 million. Imperial still owns 19% of the business, and saw the value of that stake rise from £45 million in July 2013 to £73 million in December, and £82 million at float. The big gains in Imperial's portfolio come just before its offspring head for the stock market. Now while Cummings was being cagey about naming names, he made it clear the pipeline of floats is looking good. Word is that companies like Cell Medica (cellular therapeutics), PsiOxus (biotech), Veryan Medical (vascular disease) and PolyTherics (biopharma) are well on their way to listings. Not only are Imperial companies maturing, but so too is the breadth and depth of its management. At the same time, its investor base (dominated by Imperial College itself and Invesco Perpetual) is a bunch of long-term holders. After a roller-coaster first eight years, it looks the right time to get on board for the next eight.' |
Posted at 27/1/2009 16:24 by jammytass all the tec for the future in 1 cmpy this is a must for all tec investors |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
